Results 61 to 70 of about 20,045 (250)

Triplex Hybridization-Based Nanosystem for the Rapid Screening of Pneumocystis Pneumonia in Clinical Samples

Journal of Fungi, 2020
Pneumocystis pneumonia (PcP) is a disease produced by the opportunistic infection of the fungus Pneumocystis jirovecii. As delayed or unsuitable treatments increase the risk of mortality, the development of rapid and accurate diagnostic tools for PcP are
Luis Pla, Anna Aviñó, Ramón Eritja, Alba Ruiz-Gaitán, Javier Pemán, Vicente Friaza, Enrique J. Calderón, Elena Aznar, Ramón Martínez-Máñez, Sara Santiago-Felipe   +9 more
doaj   +1 more source

Promising Prodiginins Biological Activities

Chemistry &Biodiversity, EarlyView.
ABSTRACT Prodiginins are a large family of at least 34 pyrrolic compounds, including the well‐studied red pigment prodigiosin. Prodiginins are produced by several microorganisms displaying broad biological activities, including antimicrobial, antiviral, antiparasitic, antiproliferative, and immunosuppressive activities.
María F. Ladetto, Melisa E. Gantner, Boris E. Rodenak‐Kladniew, Santiago Rodriguez, María L. Cuestas, Alan Talevi, Guillermo R. Castro   +6 more
wiley   +1 more source

Pneumocystis jirovecii in Spanish Patients With Heart Failure [PDF]

Frontiers in Public Health, 2019
Objective: Pneumocystis colonization is frequent in patients with chronic obstructive pulmonary disease (COPD) producing local and systemic inflammation. Heart failure is also a common comorbidity among patients with COPD. Heart failure is a chronic, frequent, and disabling condition with high morbidity and mortality, but with a modifiable course where
Izarbe Merino-Casallo, Izarbe Merino-Casallo, Vicente Friaza, Vicente Friaza, Sebastián Menao, Sebastián Menao, José María Domingo, José María Domingo, Susana Olivera, Susana Olivera, Enrique J. Calderón, Enrique J. Calderón, Miguel Ángel Torralba, Miguel Ángel Torralba   +13 more
openaire   +5 more sources

Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study [PDF]

, 2016
PJP diagnosis by methenamine and PCR in participating centers.
Bin Du, Chun-Yao Wang, Jin-Min Peng, Li Weng, Li-Qin Feng, Lie Chen, Qing-Yuan Zhan, Wei Jiang, Xiao-Yun Hu, Xu Huang   +9 more
core   +2 more sources

Identification of B-cell and T-cell specific peptide vaccine for Pneumocystis jirovecii [PDF]

, 2023
Pneumocystis jirovecii is a fungal pathogen that causes a severe lung infection primarily in individuals with compromised immune systems. The high morbidity and mortality associated with Pneumocystis jirovecii pneumonia (PJP) highlight the need for ...
Sumedha Balaji , Sathish Sankar
core   +3 more sources

Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia

BMC Infectious Diseases, 2009
Background Pneumocystis jirovecii, formerly named Pneumocystis carinii, is one of the most common opportunistic infections in human immunodeficiency virus (HIV)-infected patients.
Yoon Sung, Kwon Yong, Kim Dong-Min, Cho Ju-Yeon, Lee Seung   +4 more
doaj   +1 more source

Utility of BioFire FilmArray Pneumonia Panel Plus in a High‐Risk Cohort: Children Post Allogeneic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pulmonary complications due to infection contribute significantly to post‐haematopoietic stem cell transplant (HCT) morbidity and mortality. Standard microbiological investigations, when performed on bronchoalveolar lavage (BAL) fluid, can take days to weeks to confirm a diagnosis.
Hannah Walker, Theresa Cole, Liam Gubbels, Helen Pham, Melanie Neeland, Diane Hanna, Vanessa Clifford, Shivanthan Shanthikumar, Gabrielle M. Haeusler   +8 more
wiley   +1 more source

Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii. [PDF]

, 2017
BACKGROUND.: There is limited information on the association between colonization density of upper respiratory tract colonizers and pathogen-specific pneumonia.
Ahmed, Dilruba, Antonio, Martin, Baggett, Henry C, Baillie, Vicky L, Brooks, W Abdullah, Deloria Knoll, Maria, DeLuca, Andrea N, Driscoll, Amanda J, Feikin, Daniel R, Fu, Wei, Gitahi, Caroline W, Hammitt, Laura L, Higdon, Melissa M, Hossain, Lokman, Howie, Stephen RC, Karron, Ruth A, Kotloff, Karen L, Levine, Orin S, Madhi, Shabir A, Maiga, Abdoul Aziz, Maloney, Susan A, Moore, David P, Morpeth, Susan C, Murdoch, David R, Mwaba, John, Mwenechanya, Musaku, O'Brien, Katherine L, Olutunde, Emmanuel, Park, Daniel E, PERCH Study Group, Prosperi, Christine, Scott, J Anthony G, Shi, Qiyuan, Sylla, Mamadou, Thamthitiwat, Somsak, Thea, Donald M, Watson, Nora L, Zeger, Scott L   +37 more
core   +1 more source

Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation

Alimentary Pharmacology &Therapeutics, EarlyView.
In liver transplant recipients with coexistent inflammatory bowel disease, incidence of infectious events observed between those exposed to ‘gut‐specific’ and ‘systemic’ biologics were similar. Biologic choice should not be influenced by concerns regarding their co‐prescription with transplant immunosuppression.
Simone Chin, Danny Con, Patrick Hilley, Crispin Corte, Ken Liu, Adam Testro, Peter De Cruz, Matthew C. Choy, Ashish Srinivasan   +8 more
wiley   +1 more source

Molecular detection of Pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of Iran

Current Medical Mycology, 2015
Background and Purpose: Pneumocystis pneumonia, caused by Pneumocystis jirovecii, is a fatal disease threatening patients with AIDS or immunosuppression.
Mahmood Parian, Abdolmajid Fata, Mohammad Javad Najafzadeh, Fariba Rezaeitalab   +3 more
doaj